DIFLUNISAL
Generic: DIFLUNISAL
Teva Pharmaceuticals USAManufacturer
ORALRoute
DIFLUNISALActive Substance
1992-07-31Original Approval
DIFLUNISAL is FDA application ANDA073673, sponsored by TEVA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NAUSEA
49 reports
2
FATIGUE
43 reports
3
PAIN
39 reports
4
DRUG INEFFECTIVE
34 reports
5
ARTHRALGIA
33 reports
6
FALL
31 reports
7
HEADACHE
30 reports
8
DIARRHOEA
29 reports
9
PLATELET COUNT DECREASED
29 reports
10
DRUG HYPERSENSITIVITY
27 reports